Skip to main content
Industry News
Guardant's liquid biopsy assay OK'd for tumor profiling
8/10/2020

The FDA has approved Guardant Health's Guardant360 Dx to be used to profile tumor mutations in patients with any solid malignant tumor.

Full Story: